Spontaneous ex vivo reactivity of CD8+ NW1539 T cells against NY-ESO-1 p94-102 peptide. ELISPOT analysis of the recognition of T2.A3 target cells unpulsed or pulsed with NY-ESO-1 p94-102 peptide by unsensitized CD8+ selected T cells from patient NW1539.